RGNX

Regenxbio INC

-$236.3M

Net Activity

Institutions Holding

177

Popularity Rank

#3196

Avg Weight

0.06%

Total Value

$360.6M

Ownership Trend

177 institutions currently hold RGNX, with 89 net buyers and 87 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

87

Net Buying Institutions

89

Key Holders

View all 177 holding institutions

Quarterly Activity

Recent Activity

+$199.6M

Total Buy Value

$205.8M

Total Sell Value

New buy28
Trim59
Add61
Sold out28

89

Net Buyers

87

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$518K

Total Est. Value

43K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
Stephen J. Pakola2026-07-01$518K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding REGENXBIO INC (RGNX)?
Major stakeholders currently include BlackRock, Inc. ($48.5M), Redmile Group, LLC ($36.6M), Jpmorgan Chase & Co ($27.1M). Based on the latest 13F filings, there are a total of 177 tracked investment funds and institutions maintaining positions in RGNX.
What is the overall institutional sentiment toward RGNX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $236.3M, driven by 89 managers accumulating shares while 87 reduced their exposure.
Which institutions have been selling or reducing their RGNX positions?
In the latest period, 59 funds trimmed their holdings, and 28 managers completely exited their positions. The aggregate reported sell value was $205.8M.
Are there any notable investors adding RGNX to their portfolios?
Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 61 existing holders added to their shares. The total reported buy value for the quarter amounted to $199.6M.

Related Stocks